Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Adaptive Biotechnologies Corp 1165 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98109 USA

www.adaptivebiotech.com Employees: 619 P: 206-659-0067 F: 206-659-0667

Sector:

Medical

Description:

Adaptive Biotechnologies Corporation is a commercial-stage biotech company. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of disease. The company's product pipeline includes immunoSEQ, clonoSEQ and cellular therapy which are in clinical stage. Adaptive Biotechnologies Corporation is based in Seattle, Washington.

Key Statistics

Overview:

Market Capitalization, $K 2,674,691
Enterprise Value, $K 2,626,771
Shares Outstanding, K 152,665
Float, K 142,894
% Float 93.60%
Short Interest, K 8,760
Short Float 5.74%
Days to Cover 4.43
Short Volume Ratio 0.23
% of Insider Shareholders 6.40%
% of Institutional Shareholders 99.17%

Financials:

Annual Sales, $ 178,960 K
Annual Net Income, $ -159,490 K
Last Quarter Sales, $ 93,970 K
Last Quarter Net Income, $ 9,550 K
EBIT, $ -76,490 K
EBITDA, $ -65,440 K

Growth:

1-Year Return 162.41%
3-Year Return 90.92%
5-Year Return -67.78%
5-Year Revenue Growth 110.37%
5-Year Earnings Growth -1.98%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.15 on 11/05/25
Next Earnings Date 02/10/26 [--]
Earnings Per Share ttm -0.75
EPS Growth vs. Prev Qtr 11.76%
EPS Growth vs. Prev Year 31.82%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ADPT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -58.39%
Return-on-Assets % -22.25%
Profit Margin % -89.12%
Debt/Equity 0.00
Price/Sales 10.63
Price/Cash Flow N/A
Price/Book 13.06
Book Value/Share 1.34
Interest Coverage -12.78
60-Month Beta 2.18
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar